Given Sobi's cash flow generation from its hemophilia business and mature product Synagis, the firm ended 2024 with a net debt/EBITDA ratio of 1.6 times. We expect the firm can support this level of ...

Sobi had been the notorious gang leader and confessed ... Ssegirinya was a maverick who made his name from religiously contributing to public affairs debate on radio, a devastatingly effective ...

Correspondence to Dr Ricardo Grieshaber-Bouyer, Division of Rheumatology, Department of Medicine V (Hematology, Oncology and Rheumatology), Heidelberg University Hospital, Heidelberg, Germany; Ricardo ...

Sobi has completed the acquisition of AstraZeneca’s Synagis (palivizumab) for $1.5 billion in cash and shares, plus certain conditional payments. As part of the deal, first announced in August ...

Swedish Orphan Biovitrum (Sobi) has agreed a $1.7 billion merger deal to acquire CTI BioPharma and its recently-approved Vonjo drug for people with blood cancer myelofibrosis and severe ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Catherine, Jaden, Anne, Phillip, Jamal and Esteban are some of the names that we'll be seeing less of in 2025, a new survey by BabyCenter has revealed. Other names falling in popularity include ...

Edo State lawmaker Natasha Osawaru has accepted the marriage proposal of music star Innocent “2Baba” Idibia. In a new video on Thursday morning, 2Baba asked Natasha to marry him, confirming their ...

Priscilla Ojo, daughter of Nollywood actress Iyabo Ojo, has said that even though marriage can be scary, she is confident that her own story will be different.

Shares of Swedish Orphan Biovitrum AB (STO:SOBI) fell 3% as the company's fourth-quarter earnings report revealed mixed results. While overall Q4 revenue met consensus expectations, sales of its key ...